One study has showed that the mutation of Vhl and TP53, two most important genes in development of ccRCC is associated with the change of N6-methyladenosine (m6A) regulatory genes (Zhou J. et al., 2019), suggesting that m6A modification may play an important role in ccRCC. Here, TP53 is linked to nonpapillary renal cell carcinoma.